Serum S100B and LDH at baseline and during therapy predict the outcome of metastatic melanoma patients treated with BRAF inhibitors

Gassenmaier, Maximilian; Lenders, Max M.; Forschner, Andrea; Leiter, Ulrike; Weide, Benjamin; Garbe, Claus; Eigentler, Thomas K.; Wagner, Nikolaus B.

dc.contributor.author	Gassenmaier, Maximilian
dc.contributor.author	Lenders, Max Matthias
dc.contributor.author	Forschner, Andrea Lydia
dc.contributor.author	Leiter-Stöppke, Ulrike
dc.contributor.author	Weide, Benjamin Matthias
dc.contributor.author	Garbe, Claus
dc.contributor.author	Eigentler, Thomas
dc.contributor.author	Wagner, Nikolaus B.
dc.date.accessioned	2021-08-31T08:31:00Z
dc.date.available	2021-08-31T08:31:00Z
dc.date.issued	2021
dc.identifier.issn	1776-260X
dc.identifier.uri	http://hdl.handle.net/10900/118376
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s11523-021-00792-8	de_DE
dc.subject.ddc	610	de_DE
dc.title	Serum S100B and LDH at baseline and during therapy predict the outcome of metastatic melanoma patients treated with BRAF inhibitors	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210512015105_00848
utue.publikation.seiten	197-205	de_DE
utue.personen.roh	Gassenmaier, Maximilian
utue.personen.roh	Lenders, Max M.
utue.personen.roh	Forschner, Andrea
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Weide, Benjamin
utue.personen.roh	Garbe, Claus
utue.personen.roh	Eigentler, Thomas K.
utue.personen.roh	Wagner, Nikolaus B.
dcterms.isPartOf.ZSTitelID	Targeted Oncology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE